Patients who are dispensed donated cancer drugs must be ______.

• A. Notified by the prescribing practitioner that the cancer drugs they received were originally dispensed to another patient and were returned for redispensing through the program
• B. Notified by the pharmacist at delivery that the drugs are from the program
• C. Notified by the clinic staff that they are new
• D. Not notified

Answer: (A)

Notification to the patient that donated cancer drugs were originally dispensed to another patient and returned for redispensing through the program is required because transparency about the drug’s provenance is essential for informed consent and safety. The prescribing practitioner has the therapeutic relationship and responsibility to disclose that the medication is a donation and not a newly manufactured product, so the patient understands what they are receiving, including any potential concerns about prior handling or the redistribution process. This aligns with program policies and safeguards, reducing confusion and ensuring appropriate monitoring.